No other significant correlations were observed between miRNA expression and clinicopathological parameters [(age, tumor size, histological grade, number of axillary infiltrated lymph nodes, estrogen receptor (ER), progesterone receptor (PR) or human epidermal growth factor receptor 2 (HER2) status; chi-square test, p > 0.05)]. This evidence concerns the gene PGR and neoplasm.